Just a moment, the page is loading...
Login Register
 
♥

Ears, Nose and Throat

Smith+Nephew's Ear, Nose and Throat (ENT) portfolio consists of products for epistaxis, laryngeal and soft palate reduction, septoplasty, turbinate reduction, sinus surgery, tympanostomy, and tonsil and adenoid removal. 

To be considered for financial support in the next calendar year all applications must be submitted by May 31st. If your application is successful, funding will be confirmed by Q4 of the current calendar year at the latest.

If you wish to discuss your proposal prior to submission please send an email to studyrequest@smith-nephew.com in the email please include your contact details, details of your institution and a brief summary of your planned activity, including the Smith & Nephew product of interest.

To submit a proposal, navigate to the appropriate study type at the bottom of the page and click the ‘Submit Proposal’ button within.

Submit Idea
View All Selected
Clear All

For support consideration of pre-clinical research projects, please contact Contact Needed or your local SN representative for more information.

As the sponsor of the study, the investigator and/or institution assume responsibility for all aspects of the study.

  • Study design and protocol development
  • Institutional and regulatory approvals and reporting
    • IRB/EC approval
    • Registration on ClinicalTrials.gov
    • IND/IDE application submission
    • Serious adverse event reporting to the FDA, IRB, and Smith+Nephew
  • Study conduct in accordance with ICH GCP Guidelines and all applicable local and regulatory requirements
  • Communication of all ongoing study updates (see section below)
  • Reconciliation and closeout reporting (see section below)
  • Clinical study report submission within 90 days of study completion
  • Dissemination of study results in a peer-reviewed publication and/or at a medical meeting within 6 months of study completion

The Investigator needs to complete a study proposal and budget, these will be provided once you have selected the relevant study type below.

It takes approximately 6 to 8 weeks for a proposal to be approved. Once approved the contracting process can take up to 3 months depending on the Institution’s internal contracting process. Investigator should not commence work on a proposal until a fully executed contract is in place. All contracts are with the Institution not the Investigator.

S+N will provide all or partial funding for any IIS that has been approved. S+N would prefer to provide funding to cover the device cost, rather than provide devices, but it can be done if absolutely necessary. Investigators can not be paid directly. All funding is to the institution responsible for and housing the patient data. No exceptions.

The Investigator must notify Smith+Nephew of the following updates for ongoing studies:

  • Amendments to the study protocol
  • Regulatory re-approvals
  • Serious adverse events reports
  • Achievement of study milestones related to milestone payments
  • Subject enrollment progress (e.g., first subject in, last subject in, last subject out, etc.)

A clinical study report (CSR) is required within 90 days of study completion. The CSR should be written in accordance with the ICH Guidance for Structure and Content of Clinical Study Reports. Please refer to our guidance document here. A CSR template is provided for you here.

Submission for publication in a peer-reviewed journal is required within 6 months of study completion. All publications should comply with recognized ethical standards concerning publications and authorship, including the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, established by the International Committee of Medical Journal Editors.

Smith+Nephew at least 30 days in advance of submission for publication. Additionally, we must receive evidence of submission for publication no later than 6 months following completion of the study. For research support that includes funding, the final milestone payment is dependent on submission for publication or presentation of study results.

Benefits to you: Funding support for research interests, Opportunities to collaborate with peers by participating in multi-center S&N sponsored studies and Med Ed opportunities to attend advanced courses/conferences

Benefits to S+N: Evidence to guide strategic direction for the life of the product, Clinical data to support product claims & meet regulatory requirements

SN has interest in evidence that demonstrates:

Clinical Impact - The clinical impact and outcomes associated with using SN products and technologies for various procedures, in various settings, and different patient populations. Outcome measures may include performance outcomes, clinican-reported outcomes, patient-reported outcomes.

Quality Impact - The impact of using SN products/technologies on quality of care, including physician, caregiver and patient satisfaction, and institutional quality metrics associated with the implementation of SN products.

Economic Impact - Economic benefits associated with SN product implementation in different geographies and reimbursement / payment models.

Process Impact - Process impacts related to implementation of SN products including workflow efficiencies, operational efficiency gains, decreased procedural wait times.

Proposals that are aligned with SN research goals of evaluating the clinical and/or economic value of SN products and disease states to ultimately help patients live Life Unlimited.

The following study types may be considered for support:

  • Prospective or Retrospective clinical studies involving Smith+Nephew products and technologies
  • Health economics and outcomes research (HEOR)
  • Support with manuscript publication or abstract presentation of existing findings
  • Non-interventional research, such as epidemiology or outcomes studies, where the focus is on scientific understanding of the disease

We do not provide support for the following:

  • Proposals that are conditioned upon past or future purchases of Smith+Nephew products
  • Requests that create a conflict of interest for Smith+Nephew


  • Investigator Initiated Studies

    A clinical study designed and initiated by an investigator, whereby S+N provide funding (monetary or medical devices) but do not act as Sponsor. Any type of study design (qualitative/quantitative) can be an IIS as the design of the study and proposal submitted to S+N for consideration comes directly from the Investigator/HCP.
    Read More

  • Collaborative Clinical Research

    A clinical activity whereby the design and/or conduct of said activity is done jointly to collaborate on fulfilling the objectives of the activity.




    Read More

  • Manuscript/Abstract Preparation

    Any type of clinical research whereby an investigator/HCP approaches S+N to ask for assistance (monetary or resource) to analyse and/or write up their existing data (external to S+N) for publication or as a conference proceeding.


    Read More

  • Real World Evidence
     

    The collection or extraction of data from routine patient treatment, that is available within the patient medical record (paper or EMR) or at the time treatment/procedure.





    Read More
We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential.
The content on this website may not be approved for use in your specific region or country. Smith+Nephew is not responsible for any interactions or dealings you have via this website that do not comply with applicable laws and regulations in your jurisdiction. By continuing to use this website, you acknowledge and agree the terms of this notice.
◊Trademark of Smith+Nephew. Product information is for educational purposes only, and not all products or indications are licensed in every country.